BEST CITIES PERCENTAGE BELOW THE NATIONAL CRIME SCORE
Caledon, Ont. -70%
Wellington County, Ont. 58
Halton Region, Ont. 58
Lévis, Que. 51
Nottawasaga, Ont. 50
York Region, Ont. 49
Richelieu Saint-Laurent, Que. 48
South Simcoe, Ont. 44
Vaudreuil-Soulange MRC, Que. 44
Blainville, Que. 42
Sources: 2009 and 1999 Crime Severity Index data from the Canadian Centre for Justice Statistics, Maclean’s
14.10.10
MEDICAL FAME DEPENDS ON PUBLICATION in a WELL-KNOWN LANGUAGE.
LUND- HUNTINGTON'S CHOREA
Progressive and inheritable chorea had been described before 1872, and the most complete clinical description, even including the component of dementia, had been published in Norway by the district physician in Setesdal, Johan Christian LUND as early as in 1859. This report received no international attention and was certainly unknown to Huntington. It was not translated into English until 1959.
A rare disease of the central nervous system characterized by progressive dementia with grimacing, gesticulation, ataxic movements, finger twitching, dysarthria, speech disorders and other bizarre involuntary movements.
On February 15, 1872 George Huntington gave his classic presentation On Chorea at the Meigs and Mason Academy of Medicine, Middleport, Ohio. He was only twenty-two at the time. His lecture was received with acclaim, so he sent his manuscript to the Medical and Surgical Reporter of Philadelphia, where it appeared on 13 April 1872.
An abstract was published in the German literature by Adolf Kussmaul (1822-1902) and Carl Wilhelm Hermann Nothnagel (1841-1905) in 1872 and thereafter the eponym was increasingly used by European authors. Huntington recognised the hereditary nature of the condition, stating in his original paper "When either or both the parents have shown manifestations of the disease, one or more of the offspring invariably suffer from the condition. It never skips a generation to again manifest itself in another. Once having yielded its claims, it never regains them."
Progressive and inheritable chorea had been described before 1872, and the most complete clinical description, even including the component of dementia, had been published in Norway by the district physician in Setesdal, Johan Christian LUND as early as in 1859. This report received no international attention and was certainly unknown to Huntington. It was not translated into English until 1959.
George Huntington born April 9, 1850, East Hampton, Long Island, New York; died March 3, 1916, Cairo, New York.
Huntington's choreaA rare disease of the central nervous system characterized by progressive dementia with grimacing, gesticulation, ataxic movements, finger twitching, dysarthria, speech disorders and other bizarre involuntary movements.
On February 15, 1872 George Huntington gave his classic presentation On Chorea at the Meigs and Mason Academy of Medicine, Middleport, Ohio. He was only twenty-two at the time. His lecture was received with acclaim, so he sent his manuscript to the Medical and Surgical Reporter of Philadelphia, where it appeared on 13 April 1872.
An abstract was published in the German literature by Adolf Kussmaul (1822-1902) and Carl Wilhelm Hermann Nothnagel (1841-1905) in 1872 and thereafter the eponym was increasingly used by European authors. Huntington recognised the hereditary nature of the condition, stating in his original paper "When either or both the parents have shown manifestations of the disease, one or more of the offspring invariably suffer from the condition. It never skips a generation to again manifest itself in another. Once having yielded its claims, it never regains them."
13.10.10
EMIGRATION of TALENT.
After two years in Toronto Dalla Lana School of Public Health Dean Jack MANDEL PhD MPH has moved to Menlo Park, California to become Chief Scientist at EXPONENT.
Dr. Jack S. Mandel has rejoined Exponent as Chief Science Officer. Most recently he was Professor and Director of the Dalla Lana School of Public Health, University of Toronto. From 2002-2008, Dr. Mandel was at Emory University in Atlanta where he served as Rollins Professor and Chair of the Department of Epidemiology, in the Rollins School of Public Health and Deputy Director for Cancer Control and Population Sciences in the Winship Cancer Institute. While at Emory, he was selected as a Georgia Cancer Coalition (GCC) Distinguished Cancer Scholar. From 1999-2002, Dr. Mandel was a Group Vice President at Exponent.
Dr. Mandel was a member of the University of Minnesota faculty from 1975-1999. From 1995 to 1999, he was the Head of the Division of Environmental and Occupational Health in the School of Public Health. In 1996, he received the distinguished honor of being named to the endowed Mayo Chair in Public Health. In 1997, he was the recipient of the Leonard M. Schuman Award for Excellence in Teaching. During his tenure at the University of Minnesota, Dr. Mandel served on a number of international, national, state, and local committees. He has also served as a consultant to industry, professional associations, and governmental agencies.
Dr. Mandel has conducted many case-control, cohort (both prospective and retrospective), cross-sectional, experimental, and methodological studies. He has published more than 200 articles related to epidemiology, including studies of prostate, colorectal, kidney, pancreatic, breast, lung, stomach, hematopoietic and skin cancers. These studies have evaluated a variety of potential etiologic factors including occupational exposures, radiation, pesticides and other chemicals, hormones, medications, diet, alcohol, and tobacco, as well as other lifestyle factors.
Dr. Jack Mandel Joins Exponent as Chief Science Officer
News
September 1, 2010
Dr. Jack S. Mandel has rejoined Exponent as Chief Science Officer. Most recently he was Professor and Director of the Dalla Lana School of Public Health, University of Toronto. From 2002-2008, Dr. Mandel was at Emory University in Atlanta where he served as Rollins Professor and Chair of the Department of Epidemiology, in the Rollins School of Public Health and Deputy Director for Cancer Control and Population Sciences in the Winship Cancer Institute. While at Emory, he was selected as a Georgia Cancer Coalition (GCC) Distinguished Cancer Scholar. From 1999-2002, Dr. Mandel was a Group Vice President at Exponent.
Dr. Mandel was a member of the University of Minnesota faculty from 1975-1999. From 1995 to 1999, he was the Head of the Division of Environmental and Occupational Health in the School of Public Health. In 1996, he received the distinguished honor of being named to the endowed Mayo Chair in Public Health. In 1997, he was the recipient of the Leonard M. Schuman Award for Excellence in Teaching. During his tenure at the University of Minnesota, Dr. Mandel served on a number of international, national, state, and local committees. He has also served as a consultant to industry, professional associations, and governmental agencies.
Dr. Mandel has conducted many case-control, cohort (both prospective and retrospective), cross-sectional, experimental, and methodological studies. He has published more than 200 articles related to epidemiology, including studies of prostate, colorectal, kidney, pancreatic, breast, lung, stomach, hematopoietic and skin cancers. These studies have evaluated a variety of potential etiologic factors including occupational exposures, radiation, pesticides and other chemicals, hormones, medications, diet, alcohol, and tobacco, as well as other lifestyle factors.
Subscribe to:
Posts (Atom)